Helen Usansky

Sr. Director And Head Of Clinical Pharmacology at Insmed

Helen Usansky has over 28 years of work experience in the field of clinical pharmacology. Helen started their career at Allergan in 1992 as a Scientist, specializing in PKDM. Helen then joined Johnson & Johnson, PRD as a Principal Scientist, focusing on PKPD. In 2006, Helen joined Bristol-Myers Squibb as a Senior Research Investigator in Clinical Discovery, Oncology/Immunology.

In 2008, they became the Director and Head of Pharmacokinetics, Translational Medicine at Ikaria. Following this, Helen founded ClinPharm Pro LLC in 2011, where they served as the President and Clinical Pharmacology Consultant for six years. Helen then joined Asana BioSciences, LLC in 2017 as the Director of DMPK and Clinical Pharmacology, before progressing to the role of Senior Director, Clinical Pharmacology and DMPK in 2019.

Currently, Helen is working at Insmed Incorporated as the Senior Director and Head of Clinical Pharmacology, a position they have held since May 2020. Throughout their career, Helen has demonstrated their expertise and leadership in the field of clinical pharmacology.

Helen Usansky completed their educational journey with a PhD in Pharmaceutical Sciences from Rutgers University, where they studied from 2000 to 2004. Prior to that, they served as a Research Fellow at the University of California, San Francisco - School of Pharmacy from 1989 to 1991, with the specifics of their research field unknown. Additionally, Helen holds an MD degree in Medicine from China Medical University and an MSc in Pharmacology & Pharmacokinetics from Dalian Medical University, although the years of completion for these degrees are not provided.

In terms of their additional certifications, Helen obtained a certification in "Holding Your Team Accountable" from LinkedIn in February 2023. Helen also completed several Coursera courses, including "Dynamical Modeling Methods for Systems Biology" in May 2014 and "Computing for Data Analysis" as well as "Computing for Data Analysis Using R" in October 2013. The details of these courses' institutions and their completion date for the "Fisher / Shafer NONMEM Course" are not provided.

Links

Previous companies

Bristol-Myers Squibb logo

Timeline

  • Sr. Director And Head Of Clinical Pharmacology

    May, 2020 - present

View in org chart